Zydus Lifesciences Limited, a formidable name in the pharmaceutical realm, proudly announces its final endorsement from the United States Food and Drug Administration (USFDA) for its Sugammadex Injection variants – 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL), Single-Dose Vial. This significant stamp of approval propels Zydus into the spotlight in the […]
Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL), Single-Dose Vial from the US Food and Drug Administration (FDA). The product is a generic of Bridion (Sugammadex) of Merck. It has approval […]
